Clinical Trials
138 trialsA-TRAIN
National Cancer Center, Japan
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Beijing Friendship Hospital
STILVARCA
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
The Epigenetic Regulatory Role of P-element Induced Wimpy Testis (Piwi) Interacting RNA-823 (piR-823) in Ovarian Cancer Progression
Ain Shams University
Artificial Intelligence Model for Growth Prediction of Ovarian Cancer Organoids
Chongqing University Cancer Hospital
BRCA 1/2 Status as a Predictive Factor to Response to Platinum Based Chemotherapy in Cancer Ovary
Assiut University
HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China
Chongqing University Cancer Hospital
STOPOVCA
Radboud University Medical Center
ERASGYNBS002
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
SUROVA
Clinica Universidad de Navarra, Universidad de Navarra
Study on Symptom Clusters During Chemotherapy in Ovarian Cancer Patients With Different Chinese Medicine Constitution
Affiliated Hospital of Jiaxing University
IMMUNOPARP
Centre Georges Francois Leclerc
Predictors of Ovarian Cancer and Endometrial Cancer for Artificial-Intelligence-Based Screening Tools
Hasanuddin University
New Prognostic Index for Neoadjuvant Chemotherapy Outcome in Patients With Advanced High-grade Serous Ovarian Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Doppler Ultrasound and CT Versus Laparoscopy in Assessment of Ovarian Malignancy
Mansoura University
Factors Affecting the Prognosis of Early Ovarian Cancer
Far Eastern Memorial Hospital
A Real-World Patient-Reported Outcomes Study in Patients With Long-Term Use of Niraparib
Peking Union Medical College Hospital
Dynamic Monitoring of ctDNA Predicts Recurrence of Advanced Ovarian Cancer After Primary Treatments
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
The Culture of Ovarian Cancer Organoids and Drug Screening
Chongqing University Cancer Hospital
The Culture of Advanced or Recurrent Ovarian Cancer Organoids and Drug Screening
Chongqing University Cancer Hospital
Clinical Application of 68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence
RenJi Hospital
Circulating Tumor DNA Monitoring in Platinum-resistant Ovarian Cancer
Fudan University
Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study
Namida Lab
Efficacy and Adverse Effects of Olaparib in Ovarian Cancer.
First Affiliated Hospital Xi'an Jiaotong University
Circulating Tumour DNA as a Marker of Residual Disease & Response to Adjuvant Chemotherapy in Stage I-IV Ovarian Cancer
Walter and Eliza Hall Institute of Medical Research
VATS IN PATIENTS WITH ADVANCED OVARIAN MALIGNANCIES
Alexandria University
A Prospective Cohort Study of 68ga-FAPI-pet-ct Versus FDG-pet-ct for Ovarian Cancer
The First Affiliated Hospital of Xiamen University
Appraising Medical Trial Experiences of Ovarian Cancer Patients
Power Life Sciences Inc.
Register to Describe the Treatment Pattern of Platinum-sensitive Relapsed Epithelial Ovarian Cancer Patients in Austria
Medical University Innsbruck
MITO-12
National Cancer Institute, Naples
3D-PREDICT
KIYATEC
CADENCE
MiRXES Pte Ltd
Real World Data Analysis of PARP Inhibitors Use in Patients With Ovarian Cancer
Hellenic Cooperative Oncology Group
Gen-eva
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Effects of Cytotoxic Chemotherapy and PARP Inhibition on the Genomic Contexture of Ovarian Cancer
Hellenic Cooperative Oncology Group
The Efficacy of Hyperthermic Intraperitoneal Chemotherapy to Ovarian Cancer Patients With Homologous Recombination Repair Defect and Residual: a Prospective Cohort Study
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Retrospective Study)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Prospective Study)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
Wuhan Ammunition Life-tech Co., Ltd
Evaluation of the Predictive Value of Blood Levels of Angiopoietin 1 and Endothelial Internal Tunica Cell Kinase 2 in Patients With Ovarian Cancer Treated With Chemotherapy Associated to Bevacizumab
IRCCS Azienda Ospedaliero-Universitaria di Bologna
DKI Combined With APT for Post-treatment Assessment of Ovarian Malignancies and Correlation With XRCC2 Gene
Qianfoshan Hospital
Prospective Cohort Study for Validation of Predictive Immune Biomarkers of Response to PAPR Inhibitors
Yonsei University
Efficacy and Adverse Effects of Niraparib in Ovarian Cancer.
First Affiliated Hospital Xi'an Jiaotong University
Immunohistochemical Expression of Epithelial Cell Adhesion Molecule (EpCAM) in Epithelial Ovarian Carcinoma
Sohag University
BriTROC-2
Cancer Research UK, Glasgow
Circulating Tumor DNA and BRCA Reversion Mutation in Advanced or Recurrent Ovarian Cancer Patients With Germline Mutation.
Yonsei University
GO SOAR2
NHS Grampian
Retrospective Review on PAEDIATRIC and ADOLESCENT ADNEXAL MASSES
Chinese University of Hong Kong
OCISS
Assiut University
First-line Olaparib Combined With Bevacizumab Maintenance Therapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University